| The Asia-Pacific perspective: redefining obesity and its treatment World Health Organization Sydney: Health Communications Australia, 2000 | 2488 | 2000 |
| A randomized, controlled trial of 3.0 mg of liraglutide in weight management X Pi-Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ... New England Journal of Medicine 373 (1), 11-22, 2015 | 2078 | 2015 |
| Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. A Flint, A Raben, A Astrup, JJ Holst The Journal of clinical investigation 101 (3), 515-520, 1998 | 1722 | 1998 |
| Diet, nutrition and the prevention of excess weight gain and obesity BA Swinburn, I Caterson, JC Seidell, WPT James Public health nutrition 7 (1a), 123-146, 2004 | 1695 | 2004 |
| Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study A Astrup, S Rössner, L Van Gaal, A Rissanen, L Niskanen, M Al Hakim, ... The Lancet 374 (9701), 1606-1616, 2009 | 1347 | 2009 |
| Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials R Christensen, PK Kristensen, EM Bartels, H Bliddal, A Astrup The Lancet 370 (9600), 1706-1713, 2007 | 1329 | 2007 |
| Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ... New England Journal of Medicine 363 (10), 905-917, 2010 | 1196 | 2010 |
| Effect of sibutramine on weight maintenance after weight loss: a randomised trial WPT James, A Astrup, N Finer, J Hilsted, P Kopelman, S Rössner, ... The Lancet 356 (9248), 2119-2125, 2000 | 1175 | 2000 |
| Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base RD Feinman, WK Pogozelski, A Astrup, RK Bernstein, EJ Fine, ... Nutrition 31 (1), 1-13, 2015 | 1142 | 2015 |
| Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans JM Bruun, AS Lihn, C Verdich, SB Pedersen, S Toubro, A Astrup, ... American journal of physiology-Endocrinology and metabolism 285 (3), E527-E533, 2003 | 1076 | 2003 |
| Diets with high or low protein content and glycemic index for weight-loss maintenance TM Larsen, SM Dalskov, M van Baak, SA Jebb, A Papadaki, AFH Pfeiffer, ... New England Journal of Medicine 363 (22), 2102-2113, 2010 | 1075 | 2010 |
| Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity AR Skov, S Toubro, B Rønn, L Holm, A Astrup International journal of obesity 23 (5), 528-536, 1999 | 1033 | 1999 |
| Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects A Raben, TH Vasilaras, AC Møller, A Astrup The American journal of clinical nutrition 76 (4), 721-729, 2002 | 963 | 2002 |
| Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis R Christensen, EM Bartels, A Astrup, H Bliddal Annals of the rheumatic diseases 66 (4), 433-439, 2007 | 921 | 2007 |
| Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide A Astrup, R Carraro, N Finer, A Harper, M Kunesova, MEJ Lean, ... International journal of obesity 36 (6), 843-854, 2012 | 856 | 2012 |
| Protein, weight management, and satiety D Paddon-Jones, E Westman, RD Mattes, RR Wolfe, A Astrup, ... The American journal of clinical nutrition 87 (5), 1558S-1561S, 2008 | 815 | 2008 |
| Glycemic index, glycemic load and glycemic response: an International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC) LSA Augustin, CWC Kendall, DJA Jenkins, WC Willett, A Astrup, ... Nutrition, Metabolism and cardiovascular diseases 25 (9), 795-815, 2015 | 784 | 2015 |
| The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? A Astrup, J Dyerberg, P Elwood, K Hermansen, FB Hu, MU Jakobsen, ... The American journal of clinical nutrition 93 (4), 684-688, 2011 | 747 | 2011 |
| 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 705 | 2017 |
| Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study M Maersk, A Belza, H Stødkilde-Jørgensen, S Ringgaard, E Chabanova, ... The American journal of clinical nutrition 95 (2), 283-289, 2012 | 691 | 2012 |
